O=C1[C@H]2[C@@H]3c4ccccc4[C@@H]([C@@H]2C(=O)N1c1ccc(OCc2ccccc2)cc1)[n+]1ccccc13
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?